Forty three Eighteen Advisors LLC Takes Position in Ventas, Inc. $VTR

Forty three Eighteen Advisors LLC purchased a new position in Ventas, Inc. (NYSE:VTR) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 16,255 shares of the real estate investment trust’s stock, valued at approximately $1,258,000.

Other institutional investors have also made changes to their positions in the company. Deutsche Bank AG raised its holdings in shares of Ventas by 0.7% during the fourth quarter. Deutsche Bank AG now owns 3,904,293 shares of the real estate investment trust’s stock worth $302,114,000 after acquiring an additional 27,688 shares in the last quarter. Schroder Investment Management Group boosted its position in Ventas by 3.6% during the third quarter. Schroder Investment Management Group now owns 2,487,572 shares of the real estate investment trust’s stock valued at $170,946,000 after purchasing an additional 85,340 shares during the last quarter. Cbre Investment Management Listed Real Assets LLC grew its stake in Ventas by 93.5% in the third quarter. Cbre Investment Management Listed Real Assets LLC now owns 1,750,598 shares of the real estate investment trust’s stock valued at $122,524,000 after purchasing an additional 845,694 shares in the last quarter. Focus Partners Advisor Solutions LLC grew its stake in Ventas by 182.3% in the third quarter. Focus Partners Advisor Solutions LLC now owns 23,650 shares of the real estate investment trust’s stock valued at $1,782,000 after purchasing an additional 15,273 shares in the last quarter. Finally, Union Bancaire Privee UBP SA acquired a new position in Ventas in the 4th quarter worth about $1,335,000. 94.18% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

VTR has been the subject of several research reports. UBS Group lifted their price target on Ventas from $85.00 to $93.00 and gave the company a “neutral” rating in a report on Monday, May 4th. Scotiabank dropped their price objective on Ventas from $95.00 to $88.00 and set a “sector perform” rating on the stock in a report on Thursday. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a $100.00 price objective on shares of Ventas in a research report on Tuesday. Mizuho set a $98.00 target price on shares of Ventas in a research note on Friday, May 22nd. Finally, Wells Fargo & Company boosted their target price on shares of Ventas from $93.00 to $96.00 and gave the stock an “overweight” rating in a research report on Monday, June 1st. Fifteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $96.00.

Insiders Place Their Bets

In related news, Director Walter C. Rakowich sold 1,152 shares of the company’s stock in a transaction on Thursday, May 14th. The shares were sold at an average price of $90.20, for a total transaction of $103,910.40. Following the completion of the sale, the director directly owned 28,349 shares of the company’s stock, valued at approximately $2,557,079.80. This represents a 3.90% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael J. Embler acquired 2,500 shares of the firm’s stock in a transaction that occurred on Wednesday, June 3rd. The shares were purchased at an average cost of $78.81 per share, with a total value of $197,025.00. Following the completion of the acquisition, the director owned 19,202 shares in the company, valued at $1,513,309.62. This trade represents a 14.97% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. 0.53% of the stock is currently owned by insiders.

Ventas Stock Performance

Shares of NYSE VTR opened at $81.61 on Friday. The business’s 50-day simple moving average is $85.07 and its 200-day simple moving average is $82.58. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.25 and a current ratio of 0.25. Ventas, Inc. has a 52 week low of $61.76 and a 52 week high of $91.06. The firm has a market cap of $39.68 billion, a price-to-earnings ratio of 148.38, a P/E/G ratio of 1.75 and a beta of 0.71.

Ventas (NYSE:VTR) last posted its earnings results on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.12 by ($0.01). The company had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.59 billion. Ventas had a return on equity of 2.09% and a net margin of 4.25%.The firm’s revenue for the quarter was up 22.0% compared to the same quarter last year. During the same quarter last year, the firm posted $0.84 earnings per share. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. As a group, equities research analysts expect that Ventas, Inc. will post 3.88 earnings per share for the current fiscal year.

Ventas Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, July 16th. Stockholders of record on Tuesday, June 30th will be paid a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date is Tuesday, June 30th. Ventas’s payout ratio is presently 378.18%.

Ventas Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.